228 related articles for article (PubMed ID: 33589570)
1. The lymphocyte-C-reactive protein ratio as the optimal inflammation-based score in patients with hepatocellular carcinoma underwent TACE.
Lu LH; Wei W; Li SH; Zhang YF; Guo RP
Aging (Albany NY); 2021 Feb; 13(4):5358-5368. PubMed ID: 33589570
[TBL] [Abstract][Full Text] [Related]
2. Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101.
He CB; Lin XJ
PLoS One; 2017; 12(3):e0174769. PubMed ID: 28355305
[TBL] [Abstract][Full Text] [Related]
3. Intermediate stage hepatocellular carcinoma: Comparison of the value of inflammation-based scores in predicting progression-free survival of patients receiving transarterial chemoembolization.
Liu Y; Shi M; Chen S; Wan W; Shen L; Shen B; Qi H; Cao F; Wu Y; Huang T; Chen G; Mo J; Ye D; Zhang Y; Feng Z; Fan W
J Cancer Res Ther; 2021 Jul; 17(3):740-748. PubMed ID: 34269308
[TBL] [Abstract][Full Text] [Related]
4. Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization.
Zhou DS; Xu L; Luo YL; He FY; Huang JT; Zhang YJ; Chen MS
World J Gastroenterol; 2015 May; 21(18):5582-90. PubMed ID: 25987783
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the prognostic value of inflammation-based scores in early recurrent hepatocellular carcinoma after hepatectomy.
Wang C; He W; Yuan Y; Zhang Y; Li K; Zou R; Liao Y; Liu W; Yang Z; Zuo D; Qiu J; Zheng Y; Li B; Yuan Y
Liver Int; 2020 Jan; 40(1):229-239. PubMed ID: 31652394
[TBL] [Abstract][Full Text] [Related]
6. Aspartate aminotransferase-lymphocyte ratio index and systemic immune-inflammation index predict overall survival in HBV-related hepatocellular carcinoma patients after transcatheter arterial chemoembolization.
Yang Z; Zhang J; Lu Y; Xu Q; Tang B; Wang Q; Zhang W; Chen S; Lu L; Chen X
Oncotarget; 2015 Dec; 6(40):43090-8. PubMed ID: 26506519
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the Prognostic Value of Inflammation-Based Scores in Patients with Hepatocellular Carcinoma After Anti-PD-1 Therapy.
Mei J; Sun XQ; Lin WP; Li SH; Lu LH; Zou JW; Wei W; Guo RP
J Inflamm Res; 2021; 14():3879-3890. PubMed ID: 34408469
[TBL] [Abstract][Full Text] [Related]
8. An inflammation-based prognostic index predicts survival advantage after transarterial chemoembolization in hepatocellular carcinoma.
Pinato DJ; Sharma R
Transl Res; 2012 Aug; 160(2):146-52. PubMed ID: 22677364
[TBL] [Abstract][Full Text] [Related]
9. A novel combined systemic inflammation-based score can predict survival of intermediate-to-advanced hepatocellular carcinoma patients undergoing transarterial chemoembolization.
Liu C; Li L; Lu WS; Du H; Yan LN; Wen TF; Wei WR; Jiang L; Xu MQ
BMC Cancer; 2018 Feb; 18(1):216. PubMed ID: 29466970
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil-lymphocyte Ratio Plus Prognostic Nutritional Index Predicts the Outcomes of Patients with Unresectable Hepatocellular Carcinoma After Transarterial Chemoembolization.
Liu C; Li L; Lu WS; Du H; Yan LN; Yang JY; Wen TF; Zeng GJ; Jiang L; Yang J
Sci Rep; 2017 Oct; 7(1):13873. PubMed ID: 29066730
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of the CRP/Alb and neutrophil to lymphocyte ratios in hepatocellular carcinoma patients undergoing TACE and RFA.
Shen Y; Wang H; Li W; Chen J
J Clin Lab Anal; 2019 Nov; 33(9):e22999. PubMed ID: 31418936
[TBL] [Abstract][Full Text] [Related]
13. A Novel and Validated Inflammation-Based Score (IBS) Predicts Survival in Patients With Hepatocellular Carcinoma Following Curative Surgical Resection: A STROBE-Compliant Article.
Fu YP; Ni XC; Yi Y; Cai XY; He HW; Wang JX; Lu ZF; Han X; Cao Y; Zhou J; Fan J; Qiu SJ
Medicine (Baltimore); 2016 Feb; 95(7):e2784. PubMed ID: 26886627
[TBL] [Abstract][Full Text] [Related]
14. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma.
Kinoshita A; Onoda H; Imai N; Iwaku A; Oishi M; Tanaka K; Fushiya N; Koike K; Nishino H; Matsushima M
Ann Surg Oncol; 2015 Mar; 22(3):803-10. PubMed ID: 25190127
[TBL] [Abstract][Full Text] [Related]
15. The inflammation-based scores to predict prognosis of patients with hepatocellular carcinoma after hepatectomy.
Huang J; Xu L; Luo Y; He F; Zhang Y; Chen M
Med Oncol; 2014 Apr; 31(4):883. PubMed ID: 24535607
[TBL] [Abstract][Full Text] [Related]
16. Preoperative neutrophil to lymphocyte ratio and prognostic nutritional index predict overall survival after hepatectomy for hepatocellular carcinoma.
Okamura Y; Ashida R; Ito T; Sugiura T; Mori K; Uesaka K
World J Surg; 2015 Jun; 39(6):1501-9. PubMed ID: 25670038
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of inflammatory and nutritional markers for hepatocellular carcinoma.
Xu Y; Yuan X; Zhang X; Hu W; Wang Z; Yao L; Zong L
Medicine (Baltimore); 2021 Jun; 100(25):e26506. PubMed ID: 34160470
[TBL] [Abstract][Full Text] [Related]
18. The Munich-Transarterial Chemoembolisation Score Holds Superior Prognostic Capacities Compared to TACE-Tailored Modifications of 9 Established Staging Systems for Hepatocellular Carcinoma.
Op den Winkel M; Nagel D; Op den Winkel P; Paprottka PM; Schmidt L; Bourhis H; Trojan J; Goeller M; Reiter FP; Stecher SS; De Toni EN; Gerbes AL; Kolligs FT
Digestion; 2019; 100(1):15-26. PubMed ID: 30282074
[TBL] [Abstract][Full Text] [Related]
19. A novel and validated prognostic index in hepatocellular carcinoma: the inflammation based index (IBI).
Pinato DJ; Stebbing J; Ishizuka M; Khan SA; Wasan HS; North BV; Kubota K; Sharma R
J Hepatol; 2012 Nov; 57(5):1013-20. PubMed ID: 22732513
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Role of Neutrophil-to-Lymphocyte Ratio (NLR), Lymphocyte-to-Monocyte Ratio (LMR), Platelet-to-Lymphocyte Ratio (PLR) and Lymphocyte-to-C Reactive Protein Ratio (LCR) in Patients with Hepatocellular Carcinoma (HCC) undergoing Chemoembolizations (TACE) of the Liver: The Unexplored Corner Linking Tumor Microenvironment, Biomarkers and Interventional Radiology.
Minici R; Siciliano MA; Ammendola M; Santoro RC; Barbieri V; Ranieri G; Laganà D
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
